MENU
NUVL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nuvalent (NUVL) Earnings Date & Reports

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

A.I. Advisor
published Earnings

NUVL is expected to report earnings to fall 14.12% to -146 cents per share on March 04

Nuvalent NUVL Stock Earnings Reports
Q4'25
Est.
$-1.46
Q3'25
Missed
by $0.34
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.05
Q4'24
Beat
by $0.03
The last earnings report on October 30 showed earnings per share of -170 cents, missing the estimate of -136 cents. With 73.88K shares outstanding, the current market capitalization sits at 7.06B.
View a ticker or compare two or three
NUVL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVL showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com